|Last Price$23.61||Day Change (%)0.47%|
|Open Price$23.61||Day Change ($)0.11|
|Day Range23.61–23.61||52-Week Range18.49–23.61|
As of Sat 12/09/2016 | USD
Drug-Research Firm PPD Explores Sale
Dr. Reddy's Laboratories Announces the Launch of Nystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market
Innovus Pharma Launches its Clinically Proven UriVarx™ Product for Bladder Health Through its Beyond Human® Sales and Marketing Platform in the United States
Lupin Receives FDA Approval for Generic Nuvigil® Tablets
Drugmakers Find Competition Doesn't Keep a Lid on Prices
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.